Coherus BioSciences Inc.

03/03/2021 | Press release | Distributed by Public on 03/03/2021 05:51

Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma